StemCells (STEM) spiked to a new 52-week high of $2 shortly after the market opened today (02014.06.19). The company issued a press release titled:
"StemCells, Inc. Interim Results Show Improvement in Visual Function and Slowing of Disease Progression in Phase I/II Dry AMD Trial".
STEM closed yesterday (02014.06.18) at $1.57. Right now (02014.06.19 at 10:15am EDT) STEM is at $1.86 after spiking to $2.00. Volume has been 9.15 million shares vs. a trailing-3-month daily average of 0.69 million.
No comments:
Post a Comment